Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2026-05-19 @ 10:06 AM
Study NCT ID:
NCT01709435
Status:
COMPLETED
Last Update Posted:
2023-12-22
First Post:
2012-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Malignant Solid Neoplasm | View |
| None | Recurrent Melanoma | View |
| None | Recurrent Primary Central Nervous System Neoplasm | View |
| None | Recurrent Thyroid Gland Carcinoma | View |
| None | Refractory Malignant Solid Neoplasm | View |
| None | Refractory Primary Central Nervous System Neoplasm | View |
| None | Thyroid Gland Medullary Carcinoma | View |
Keywords: